id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-D-0659-0034,FDA,FDA-2008-D-0659,"Guidance for Industry Current Good Tissue Practice and Additional Requirements for Manufacturers of Human Cells, Tissues, and Cellular and Tissue-Based Products; Availability",Notice,Notice of Availability,2011-12-30T05:00:00Z,2011,12,2011-12-30T05:00:00Z,,2024-11-11T21:35:46Z,2011-33572,1,0,0900006480f8b716
FDA-2008-D-0659-0035,FDA,FDA-2008-D-0659,"Current Good Tissue Practice (CGTP) and Additional Requirements for Manufacturers of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps).:  Guidance for Industry",Other,Guidance,2011-12-01T05:00:00Z,2011,12,2011-12-01T05:00:00Z,,2024-11-07T01:39:32Z,,1,0,0900006480f8b80a
FDA-2008-D-0659-0028,FDA,FDA-2008-D-0659,"Attachment 2 - ""Tissue Donor Physical"" (AATB Guidance Document) - [American Association of Tissue Banks - Comment] re FDA-2008-D-0659-0020",Supporting & Related Material,EREG-Electronic Regulation from Form Supporting and Related Material),2009-04-19T04:00:00Z,2009,4,,,2009-04-20T03:13:46Z,,0,0,090000648095823b
FDA-2008-D-0659-0027,FDA,FDA-2008-D-0659,"Attachment 1 - ""Prevention of Contamination and Cross-Contamination at Recovery: Practices & Culture Results"" - [American Association of Tissue Banks - Comment] re FDA-2008-D-0659-0020",Supporting & Related Material,EREG-Electronic Regulation from Form Supporting and Related Material),2009-04-19T04:00:00Z,2009,4,,,2009-04-20T03:13:45Z,,0,0,090000648095823c
FDA-2008-D-0659-0003,FDA,FDA-2008-D-0659,"Reference List - Draft Guidance for Industry: Current Good Tissue Practice (CGTP) and Additional Requirements for Manufacturers of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)",Supporting & Related Material,REF-Reference (internal unless indicated),2009-01-21T05:00:00Z,2009,1,,,2009-01-21T14:16:11Z,,0,0,0900006480821c28
FDA-2008-D-0659-0001,FDA,FDA-2008-D-0659,"Draft Guidance for Industry: Current Good Tissue Practice (CGTP) and Additional Requirements for Manufacturers of Human Cells, Tissues, and Cellular and Tissue-Based Products",Notice,NAD-Notice of Availability of Data,2009-01-16T05:00:00Z,2009,1,2009-01-16T05:00:00Z,2009-04-17T03:59:59Z,2009-01-16T21:58:23Z,E9-00919,0,0,0900006480823374
FDA-2008-D-0659-0002,FDA,FDA-2008-D-0659,"Draft Guidance for Industry: Current Good Tissue Practice (CGTP) and Additional Requirements for Manufacturers of Human Cells, tissues, and Cellular and Tissue-Based Products (HCT/Ps)",Other,GDL-Guidance (Supporting and Related Materials),2009-01-16T05:00:00Z,2009,1,2009-01-16T05:00:00Z,,2024-11-12T04:30:18Z,,1,0,0900006480821c85